Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Sep;65(3):689–698. doi: 10.1086/302532

EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.

J V Bovée 1, A M Cleton-Jansen 1, W Wuyts 1, G Caethoven 1, A H Taminiau 1, E Bakker 1, W Van Hul 1, C J Cornelisse 1, P C Hogendoorn 1
PMCID: PMC1377975  PMID: 10441575

Abstract

Osteochondromas occur as sporadic solitary lesions or as multiple lesions, characterizing the hereditary multiple exostoses syndrome (EXT). Approximately 15% of all chondrosarcomas arise within the cartilaginous cap of an osteochondroma. EXT is genetically heterogeneous, and two genes, EXT1 and EXT2, located on 8q24 and 11p11-p12, respectively, have been cloned. It is still unclear whether osteochondroma is a developmental disorder or a true neoplasm. Furthermore, it is unclear whether inactivation of both alleles of an EXT gene, according to the tumor-suppressor model, is required for osteochondroma development, or whether a single EXT germline mutation acts in a dominant negative way. We therefore studied loss of heterozygosity and DNA ploidy in eight sporadic and six hereditary osteochondromas. EXT1- and EXT2-mutation analysis was performed in a total of 34 sporadic and hereditary osteochondromas and secondary peripheral chondrosarcomas. We demonstrated osteochondroma to be a true neoplasm, since aneuploidy was found in 4 of 10 osteochondromas. Furthermore, LOH was almost exclusively found at the EXT1 locus in 5 of 14 osteochondromas. Four novel constitutional cDNA alterations were detected in exon 1 of EXT1. Two patients with multiple osteochondromas demonstrated a germline mutation combined with loss of the remaining wild-type allele in three osteochondromas, indicating that, in cartilaginous cells of the growth plate, inactivation of both copies of the EXT1 gene is required for osteochondroma formation in hereditary cases. In contrast, no somatic EXT1 cDNA alterations were found in sporadic osteochondromas. No mutations were found in the EXT2 gene.

Full Text

The Full Text of this article is available as a PDF (768.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahn J., Lüdecke H. J., Lindow S., Horton W. A., Lee B., Wagner M. J., Horsthemke B., Wells D. E. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat Genet. 1995 Oct;11(2):137–143. doi: 10.1038/ng1095-137. [DOI] [PubMed] [Google Scholar]
  2. Bellaiche Y., The I., Perrimon N. Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature. 1998 Jul 2;394(6688):85–88. doi: 10.1038/27932. [DOI] [PubMed] [Google Scholar]
  3. Bridge J. A., Nelson M., Orndal C., Bhatia P., Neff J. R. Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas. Cancer. 1998 May 1;82(9):1657–1663. doi: 10.1002/(sici)1097-0142(19980501)82:9<1657::aid-cncr10>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  4. Conrad M., Friedlander C., Goodman M. Evidence that natural selection acts on silent mutation. Biosystems. 1983;16(2):101–111. doi: 10.1016/0303-2647(83)90031-x. [DOI] [PubMed] [Google Scholar]
  5. Devilee P., van Vliet M., Bardoel A., Kievits T., Kuipers-Dijkshoorn N., Pearson P. L., Cornelisse C. J. Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res. 1991 Feb 1;51(3):1020–1025. [PubMed] [Google Scholar]
  6. Devilee P., van Vliet M., Kuipers-Dijkshoorn N., Pearson P. L., Cornelisse C. J. Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene. 1991 Feb;6(2):311–315. [PubMed] [Google Scholar]
  7. Devilee P., van den Broek M., Kuipers-Dijkshoorn N., Kolluri R., Khan P. M., Pearson P. L., Cornelisse C. J. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics. 1989 Oct;5(3):554–560. doi: 10.1016/0888-7543(89)90023-2. [DOI] [PubMed] [Google Scholar]
  8. Futreal P. A., Liu Q., Shattuck-Eidens D., Cochran C., Harshman K., Tavtigian S., Bennett L. M., Haugen-Strano A., Swensen J., Miki Y. BRCA1 mutations in primary breast and ovarian carcinomas. Science. 1994 Oct 7;266(5182):120–122. doi: 10.1126/science.7939630. [DOI] [PubMed] [Google Scholar]
  9. Gruis N. A., Abeln E. C., Bardoel A. F., Devilee P., Frants R. R., Cornelisse C. J. PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue. Br J Cancer. 1993 Aug;68(2):308–313. doi: 10.1038/bjc.1993.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hammerschmidt M., Brook A., McMahon A. P. The world according to hedgehog. Trends Genet. 1997 Jan;13(1):14–21. doi: 10.1016/s0168-9525(96)10051-2. [DOI] [PubMed] [Google Scholar]
  11. Hecht J. T., Hogue D., Strong L. C., Hansen M. F., Blanton S. H., Wagner M. Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet. 1995 May;56(5):1125–1131. [PMC free article] [PubMed] [Google Scholar]
  12. Hecht J. T., Hogue D., Wang Y., Blanton S. H., Wagner M., Strong L. C., Raskind W., Hansen M. F., Wells D. Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies. Am J Hum Genet. 1997 Jan;60(1):80–86. [PMC free article] [PubMed] [Google Scholar]
  13. Hiddemann W., Schumann J., Andreef M., Barlogie B., Herman C. J., Leif R. C., Mayall B. H., Murphy R. F., Sandberg A. A. Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet. 1984 Oct;13(2):181–183. doi: 10.1016/0165-4608(84)90059-1. [DOI] [PubMed] [Google Scholar]
  14. Isola J., DeVries S., Chu L., Ghazvini S., Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol. 1994 Dec;145(6):1301–1308. [PMC free article] [PubMed] [Google Scholar]
  15. Jagasia A. A., Block J. A., Qureshi A., Diaz M. O., Nobori T., Gitelis S., Iyer A. P. Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas. Cancer Lett. 1996 Jul 19;105(1):91–103. doi: 10.1016/0304-3835(96)04274-7. [DOI] [PubMed] [Google Scholar]
  16. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Le Merrer M., Legeai-Mallet L., Jeannin P. M., Horsthemke B., Schinzel A., Plauchu H., Toutain A., Achard F., Munnich A., Maroteaux P. A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet. 1994 May;3(5):717–722. doi: 10.1093/hmg/3.5.717. [DOI] [PubMed] [Google Scholar]
  18. Legeai-Mallet L., Margaritte-Jeannin P., Lemdani M., Le Merrer M., Plauchu H., Maroteaux P., Munnich A., Clerget-Darpoux F. An extension of the admixture test for the study of genetic heterogeneity in hereditary multiple exostoses. Hum Genet. 1997 Mar;99(3):298–302. doi: 10.1007/s004390050361. [DOI] [PubMed] [Google Scholar]
  19. Legeai-Mallet L., Munnich A., Maroteaux P., Le Merrer M. Incomplete penetrance and expressivity skewing in hereditary multiple exostoses. Clin Genet. 1997 Jul;52(1):12–16. doi: 10.1111/j.1399-0004.1997.tb02508.x. [DOI] [PubMed] [Google Scholar]
  20. Lind T., Tufaro F., McCormick C., Lindahl U., Lidholt K. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem. 1998 Oct 9;273(41):26265–26268. doi: 10.1074/jbc.273.41.26265. [DOI] [PubMed] [Google Scholar]
  21. McCormick C., Leduc Y., Martindale D., Mattison K., Esford L. E., Dyer A. P., Tufaro F. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet. 1998 Jun;19(2):158–161. doi: 10.1038/514. [DOI] [PubMed] [Google Scholar]
  22. Mertens F., Rydholm A., Kreicbergs A., Willén H., Jonsson K., Heim S., Mitelman F., Mandahl N. Loss of chromosome band 8q24 in sporadic osteocartilaginous exostoses. Genes Chromosomes Cancer. 1994 Jan;9(1):8–12. doi: 10.1002/gcc.2870090103. [DOI] [PubMed] [Google Scholar]
  23. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Philippe C., Porter D. E., Emerton M. E., Wells D. E., Simpson A. H., Monaco A. P. Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses. Am J Hum Genet. 1997 Sep;61(3):520–528. doi: 10.1086/515505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Raskind W. H., Conrad E. U., 3rd, Matsushita M., Wijsman E. M., Wells D. E., Chapman N., Sandell L. J., Wagner M., Houck J. Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses. Hum Mutat. 1998;11(3):231–239. doi: 10.1002/(SICI)1098-1004(1998)11:3<231::AID-HUMU8>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  26. Raskind W. H., Conrad E. U., Chansky H., Matsushita M. Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet. 1995 May;56(5):1132–1139. [PMC free article] [PubMed] [Google Scholar]
  27. Raskind W. H., Conrad E. U., Matsushita M. Frequent loss of heterozygosity for markers on chromosome arm 10q in chondrosarcomas. Genes Chromosomes Cancer. 1996 Jun;16(2):138–143. doi: 10.1002/(SICI)1098-2264(199606)16:2<138::AID-GCC8>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  28. Schmale G. A., Conrad E. U., 3rd, Raskind W. H. The natural history of hereditary multiple exostoses. J Bone Joint Surg Am. 1994 Jul;76(7):986–992. doi: 10.2106/00004623-199407000-00005. [DOI] [PubMed] [Google Scholar]
  29. Sheffield V. C., Beck J. S., Kwitek A. E., Sandstrom D. W., Stone E. M. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics. 1993 May;16(2):325–332. doi: 10.1006/geno.1993.1193. [DOI] [PubMed] [Google Scholar]
  30. Stickens D., Clines G., Burbee D., Ramos P., Thomas S., Hogue D., Hecht J. T., Lovett M., Evans G. A. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat Genet. 1996 Sep;14(1):25–32. doi: 10.1038/ng0996-25. [DOI] [PubMed] [Google Scholar]
  31. Vindeløv L. L., Christensen I. J., Nissen N. I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983 Mar;3(5):323–327. doi: 10.1002/cyto.990030503. [DOI] [PubMed] [Google Scholar]
  32. Weber J. L., May P. E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet. 1989 Mar;44(3):388–396. [PMC free article] [PubMed] [Google Scholar]
  33. Wells D. E., Hill A., Lin X., Ahn J., Brown N., Wagner M. J. Identification of novel mutations in the human EXT1 tumor suppressor gene. Hum Genet. 1997 May;99(5):612–615. doi: 10.1007/s004390050415. [DOI] [PubMed] [Google Scholar]
  34. Wicklund C. L., Pauli R. M., Johnston D., Hecht J. T. Natural history study of hereditary multiple exostoses. Am J Med Genet. 1995 Jan 2;55(1):43–46. doi: 10.1002/ajmg.1320550113. [DOI] [PubMed] [Google Scholar]
  35. Willms R., Hartwig C. H., Böhm P., Sell S. Malignant transformation of a multiple cartilaginous exostosis--a case report. Int Orthop. 1997;21(2):133–136. doi: 10.1007/s002640050136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wuyts W., Van Hul W., De Boulle K., Hendrickx J., Bakker E., Vanhoenacker F., Mollica F., Lüdecke H. J., Sayli B. S., Pazzaglia U. E. Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am J Hum Genet. 1998 Feb;62(2):346–354. doi: 10.1086/301726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wuyts W., Van Hul W., Wauters J., Nemtsova M., Reyniers E., Van Hul E. V., De Boulle K., de Vries B. B., Hendrickx J., Herrygers I. Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet. 1996 Oct;5(10):1547–1557. doi: 10.1093/hmg/5.10.1547. [DOI] [PubMed] [Google Scholar]
  38. Yamaguchi T., Toguchida J., Wadayama B., Kanoe H., Nakayama T., Ishizaki K., Ikenaga M., Kotoura Y., Sasaki M. S. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Anticancer Res. 1996 Jul-Aug;16(4A):2009–2015. [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES